Latest current cash for 1295.TWO: $310M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Synbio Tech (1295.TWO) currently reports a current cash of $310M as of June 2026. That compares with $410M in the prior-year period — down 25.3% year over year. Use the charts on this page to explore Synbio Tech's current cash history and peer comparisons.
Synbio Tech's current cash decreased from $410M to $310M — a 25.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Synbio Tech reported $310M in current cash as of June 2026. That compares with $410M in the prior-year period — down 25.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $310M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Synbio Tech, and consider following 1295.TWO for alerts when major investors trade the stock.
Synbio Tech is classified in the Healthcare sector. On current cash, it currently shows $310M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 1295.TWO with unrelated industries.